Mani Gajendiran

852 citations
31 papers · 689 indexed · h-index 16

Mani Gajendiran

30 papers receiving 680 citations

Peers

Mani Gajendiran
Comparison fields: 5 of 91
  • Biomaterials 275
  • Molecular Medicine 79
  • Pharmaceutical Science 90
  • Biomedical Engineering 277
  • Complementary and alternative medicine 33
Replace С. Н. Морозкина with:
С. Н. Морозкина Russia
Cinzia Scialabba Italy
Christiane Bertachini Lombello Brazil
Isadora C. Carvalho Brazil
Uzma Hayat China
Haile Fentahun Darge Taiwan
Thashree Marimuthu South Africa
Tiantian Sun China
P.R. Anil Kumar India
Andrey N. Kuskov Russia
Mani Gajendiran relative to С. Н. Морозкина Russia С. Н. Морозкина's profile →
Citations per field
00.5×10×15×20×
С. Н. Морозкина · 1×
Citations per year

Countries citing papers authored by Mani Gajendiran

Since Specialization
Citations

This map shows the geographic impact of Mani Gajendiran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mani Gajendiran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mani Gajendiran more than expected).

Fields of papers citing papers by Mani Gajendiran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mani Gajendiran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mani Gajendiran. The network helps show where Mani Gajendiran may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mani Gajendiran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mani Gajendiran Line = papers co-authored together Mani Gajendiran links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20244
3 202326
4 201924
5 201913
6 20194
7 201919
8 201941
9 201913
10 20187
11 201739
12 2017103
13 201710
14 201727
15 201658
16 201615
17 20165
18 201348
19 201252
20 20117

About Mani Gajendiran

Mani Gajendiran is a scholar working on Biomaterials, Pharmaceutical Science and Molecular Medicine, having authored 31 papers that have together received 689 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), Advanced Drug Delivery Systems (6 papers), Nanoparticles: synthesis and applications (5 papers), Electrospun Nanofibers in Biomedical Applications (4 papers), Metal complexes synthesis and properties (3 papers), Hydrogels: synthesis, properties, applications (3 papers), Nanoplatforms for cancer theranostics (3 papers) and Bone Tissue Engineering Materials (2 papers). The work is most often cited by research in Biomaterials (275 citations), Molecular Medicine (79 citations) and Pharmaceutical Science (90 citations). Mani Gajendiran has collaborated with scholars based in India, South Korea and Australia. Frequent co-authors include Kyobum Kim, S. Balasubramanian, Elangovan Vellaichamy, Sung Jun Kim, Jae‐Sung Rhee, Heungsoo Shin, Se‐Jeong Kim, Jonghoon Choi, N. Raaman and S. Arul Antony. Their work appears in journals such as Scientific Reports, Chemical Engineering Journal and Carbohydrate Polymers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026